JP2007506801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506801A5 JP2007506801A5 JP2006533141A JP2006533141A JP2007506801A5 JP 2007506801 A5 JP2007506801 A5 JP 2007506801A5 JP 2006533141 A JP2006533141 A JP 2006533141A JP 2006533141 A JP2006533141 A JP 2006533141A JP 2007506801 A5 JP2007506801 A5 JP 2007506801A5
- Authority
- JP
- Japan
- Prior art keywords
- modafinil
- composition
- use according
- agent
- cisplatinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 claims 17
- 229960001165 modafinil Drugs 0.000 claims 17
- 239000002246 antineoplastic agent Substances 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 7
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 3
- 229930012538 Paclitaxel Natural products 0.000 claims 3
- 229940034982 antineoplastic agent Drugs 0.000 claims 3
- -1 cisplatinum Chemical compound 0.000 claims 3
- 229960003668 docetaxel Drugs 0.000 claims 3
- 229960001592 paclitaxel Drugs 0.000 claims 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 3
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 3
- 229960004528 vincristine Drugs 0.000 claims 3
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 3
- 230000002411 adverse Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000000118 anti-neoplastic effect Effects 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 238000002651 drug therapy Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47130203P | 2003-05-16 | 2003-05-16 | |
| US10/845,836 US20040229943A1 (en) | 2003-05-16 | 2004-05-14 | Analeptic and drug combinations |
| PCT/US2004/015408 WO2004103359A1 (en) | 2003-05-16 | 2004-05-17 | Pharmaceutical combination comprising modafinil and another drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506801A JP2007506801A (ja) | 2007-03-22 |
| JP2007506801A5 true JP2007506801A5 (enExample) | 2007-06-28 |
Family
ID=33424098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533141A Withdrawn JP2007506801A (ja) | 2003-05-16 | 2004-05-17 | モダフィニルおよび他の薬剤を含んでなる製薬学的組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040229943A1 (enExample) |
| EP (1) | EP1635807A1 (enExample) |
| JP (1) | JP2007506801A (enExample) |
| KR (1) | KR20060015727A (enExample) |
| AU (1) | AU2004241110A1 (enExample) |
| BR (1) | BRPI0411176A (enExample) |
| CA (1) | CA2524870A1 (enExample) |
| EA (1) | EA200501821A1 (enExample) |
| IS (1) | IS8099A (enExample) |
| MX (1) | MXPA05012358A (enExample) |
| MY (1) | MY135829A (enExample) |
| NO (1) | NO20055173L (enExample) |
| TW (1) | TW200509896A (enExample) |
| WO (1) | WO2004103359A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20030131B1 (en) * | 2000-07-27 | 2011-03-31 | Teva Pharmaceutical Industries Ltd. | Crystalline and pure modafinil, and process of preparing the same |
| US20070053976A1 (en) * | 2002-05-17 | 2007-03-08 | Eisai R & D Management Co., Ltd. | Novel combination of drugs as antidepressant |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
| AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
| US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| WO2005099822A2 (en) * | 2004-04-13 | 2005-10-27 | Cephalon, Inc. | Reduction of drug / drug interactions with modafinil |
| EP1996291B1 (en) * | 2006-03-23 | 2010-11-17 | Yissum Research Development Company, of The Hebrew University of Jerusalem | Use of digitalis-like compounds in the treatment of affective disorders |
| DE102006015734A1 (de) * | 2006-04-04 | 2007-10-11 | Hermann, Holger Lars, Dr. | Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung |
| RU2435570C2 (ru) * | 2006-12-01 | 2011-12-10 | Нитто Денко Корпорейшн | Композиция для чрескожного всасывания |
| US20080131490A1 (en) * | 2006-12-01 | 2008-06-05 | Akinori Hanatani | Stabilized donepezil-containing patch preparation |
| WO2009145177A1 (ja) * | 2008-05-30 | 2009-12-03 | 日東電工株式会社 | ドネペジル含有貼付製剤およびその包装体 |
| CA2725484A1 (en) * | 2008-05-30 | 2009-12-03 | Eisai R&D Management Co., Ltd. | Percutaneously absorbable preparation |
| US20110224196A1 (en) * | 2010-01-07 | 2011-09-15 | Vivus, Inc. | Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5696153A (en) * | 1994-05-16 | 1997-12-09 | Napro Biotherapeutics, Inc. | Therapeutic regimen for treating patients |
| FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| WO2001013921A1 (en) * | 1999-08-23 | 2001-03-01 | Ockert David M | Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms |
| US20010034373A1 (en) * | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
| US6417184B1 (en) * | 2000-09-19 | 2002-07-09 | David M. Ockert | Triple drug therapy for the treatment and prevention of acute or chronic pain |
| US20030036555A1 (en) * | 2001-08-03 | 2003-02-20 | Boehringer Ingelheim Pharma Kg | Pramipexole for the treatment of ADHD |
| US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
| AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
| AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
| US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
-
2004
- 2004-05-14 US US10/845,836 patent/US20040229943A1/en not_active Abandoned
- 2004-05-17 MX MXPA05012358A patent/MXPA05012358A/es not_active Application Discontinuation
- 2004-05-17 WO PCT/US2004/015408 patent/WO2004103359A1/en not_active Ceased
- 2004-05-17 EA EA200501821A patent/EA200501821A1/ru unknown
- 2004-05-17 EP EP04752424A patent/EP1635807A1/en not_active Withdrawn
- 2004-05-17 KR KR1020057021727A patent/KR20060015727A/ko not_active Withdrawn
- 2004-05-17 BR BRPI0411176-1A patent/BRPI0411176A/pt not_active IP Right Cessation
- 2004-05-17 CA CA002524870A patent/CA2524870A1/en not_active Abandoned
- 2004-05-17 AU AU2004241110A patent/AU2004241110A1/en not_active Abandoned
- 2004-05-17 MY MYPI20041851A patent/MY135829A/en unknown
- 2004-05-17 TW TW093113832A patent/TW200509896A/zh unknown
- 2004-05-17 JP JP2006533141A patent/JP2007506801A/ja not_active Withdrawn
-
2005
- 2005-10-27 IS IS8099A patent/IS8099A/is unknown
- 2005-11-03 NO NO20055173A patent/NO20055173L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506801A5 (enExample) | ||
| JP2006515883A5 (enExample) | ||
| JP2013503174A5 (enExample) | ||
| JP2004519469A5 (enExample) | ||
| JP2015515475A5 (enExample) | ||
| JP2005537268A5 (enExample) | ||
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2009539769A5 (enExample) | ||
| JP2005511597A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| DK1061915T3 (da) | Farmaceutiske formuleringer af taxaner | |
| JP2013511507A5 (enExample) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法 | |
| JP2009515901A5 (enExample) | ||
| BG66113B1 (bg) | Комбиниран химиотерапевтичен състав | |
| JP2005538045A5 (enExample) | ||
| JP2009517411A5 (enExample) | ||
| JP2005508963A5 (enExample) | ||
| JP2001513506A5 (enExample) | ||
| ATE303137T1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
| JP2011500589A5 (enExample) | ||
| JP2006503095A5 (enExample) | ||
| JP2021505669A5 (enExample) | ||
| JP2007534634A5 (enExample) |